Can a blood test predict the risk of osteoarthritis? A discussion with Dr Virginia Kraus
Joint Action
Advancements in Osteoarthritis Treatment Through Immunomodulation
This chapter explores new developments in disease-modifying drugs targeting the immune and inflammatory aspects of osteoarthritis. It emphasizes a significant trial of an interleukin-1 inhibitor that revealed unexpected benefits in reducing the need for joint replacements.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
